Perelman School of Medicine

PHILADELPHIA — Targeted drug delivery is one of the more enticing applications of nanotechnology; by designing pharmaceuticals on an atomic scale, engineers hope to get them attacking diseases with newfound precision and efficiency.

A new study published by researchers at the Perelman School of Medicine at the University of Pennsylvania, the Broad Institute, and Massachusetts General Hospital, challenges the conventional concept that raising a person's HDL levels (good cholesterol) will always help lower their risk of a heart attack.

A team from the Perelman School of Medicine and the Abramson Family Cancer Research Institute at the University of Pennsylvania found that the FDA-approved drug daclizumab improved the survival of breast cancer patients taking a cancer vaccine by 30 percent, compared to those patients not taking

Perelman School of Medicine at the University of Pennsylvania researchers have discovered a mechanism involving the neurotransmitter dopamine that switches fruit fly behavior from being active during the day (diurnal) to nocturnal.

A new electronic medical record tool that tallies patients' previous radiation exposure from CT scans helps reduce potentially unnecessary use of the tests among emergency room patients with abdominal pain, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania that will be presented to

Black cardiac arrest victims who are stricken outside hospitals are less likely to receive bystander CPR and defibrillation on the scene than white patients, according to research that will be presented by a research team from the Perelman School of Medicine at the University of Pennsylvania today at the annual meeting of

PHILADELPHIA — Tracy L.

The American Heart Association (AHA) announced today that they have made their first investment through the Science & Technology Accelerator Program into CytoVas, LLC. The company was founded by Jonni S.

PHILADELPHIA — A $25 million gift to the University of Pennsylvania from alumni Mindy and Jon Gray will establish a center focused on the treatment and prevention of cancers associated with hereditary BRCA mutations.

All cells have the ability to recycle unwanted or damaged proteins and reuse the building blocks as food. But cancer cells have ramped up the system, called autophagy, and rely on it to escape damage in the face of chemotherapy and other treatments.